Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Anixa Biosciences Inc stock logo
ANIX
Anixa Biosciences
$2.92
-1.7%
$3.25
$2.07
$4.20
$94.06M0.43106,958 shs125,553 shs
CryoPort, Inc. stock logo
CYRX
CryoPort
$8.66
-0.7%
$7.52
$4.58
$9.48
$433.61M1.88538,187 shs469,714 shs
Evolus, Inc. stock logo
EOLS
Evolus
$7.23
+1.4%
$8.78
$5.71
$17.82
$467.64M1.121.11 million shs1.12 million shs
Vigil Neuroscience, Inc. stock logo
VIGL
Vigil Neuroscience
$8.05
$8.01
$1.31
$8.10
$383.91M3.331.09 million shsN/A
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Anixa Biosciences Inc stock logo
ANIX
Anixa Biosciences
-0.34%-2.30%-13.66%+16.02%-6.90%
CryoPort, Inc. stock logo
CYRX
CryoPort
-0.80%+2.71%+21.28%+42.02%-7.14%
Evolus, Inc. stock logo
EOLS
Evolus
+6.58%+11.41%-22.50%-25.65%-51.50%
Vigil Neuroscience, Inc. stock logo
VIGL
Vigil Neuroscience
0.00%0.00%-0.25%+248.48%+130.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Anixa Biosciences Inc stock logo
ANIX
Anixa Biosciences
2.4476 of 5 stars
3.53.00.00.00.93.30.0
CryoPort, Inc. stock logo
CYRX
CryoPort
3.8652 of 5 stars
4.51.00.00.02.03.31.9
Evolus, Inc. stock logo
EOLS
Evolus
4.0617 of 5 stars
3.41.00.03.52.83.30.6
Vigil Neuroscience, Inc. stock logo
VIGL
Vigil Neuroscience
2.7554 of 5 stars
4.03.00.00.00.02.50.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Anixa Biosciences Inc stock logo
ANIX
Anixa Biosciences
3.00
Buy$9.00206.12% Upside
CryoPort, Inc. stock logo
CYRX
CryoPort
3.00
Buy$12.0037.41% Upside
Evolus, Inc. stock logo
EOLS
Evolus
2.80
Moderate Buy$21.25193.71% Upside
Vigil Neuroscience, Inc. stock logo
VIGL
Vigil Neuroscience
2.00
Hold$10.8034.16% Upside

Current Analyst Ratings Breakdown

Latest ANIX, VIGL, EOLS, and CYRX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/19/2025
Anixa Biosciences Inc stock logo
ANIX
Anixa Biosciences
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$10.00
8/6/2025
CryoPort, Inc. stock logo
CYRX
CryoPort
Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
8/6/2025
CryoPort, Inc. stock logo
CYRX
CryoPort
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeSector Weight ➝ Overweight$15.00
8/6/2025
CryoPort, Inc. stock logo
CYRX
CryoPort
Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeMarket Perform ➝ Outperform$16.00
8/6/2025
Evolus, Inc. stock logo
EOLS
Evolus
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$21.00 ➝ $18.00
8/6/2025
Evolus, Inc. stock logo
EOLS
Evolus
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$27.00 ➝ $20.00
8/6/2025
Evolus, Inc. stock logo
EOLS
Evolus
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Hold$22.00
8/5/2025
Anixa Biosciences Inc stock logo
ANIX
Anixa Biosciences
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$10.00
7/22/2025
CryoPort, Inc. stock logo
CYRX
CryoPort
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$13.00
7/7/2025
CryoPort, Inc. stock logo
CYRX
CryoPort
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$13.00 ➝ $10.00
6/10/2025
Anixa Biosciences Inc stock logo
ANIX
Anixa Biosciences
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$10.00
(Data available from 8/20/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Anixa Biosciences Inc stock logo
ANIX
Anixa Biosciences
N/AN/AN/AN/A$0.59 per shareN/A
CryoPort, Inc. stock logo
CYRX
CryoPort
$228.38M1.91N/AN/A$9.53 per share0.92
Evolus, Inc. stock logo
EOLS
Evolus
$266.27M1.76N/AN/A($0.29) per share-24.95
Vigil Neuroscience, Inc. stock logo
VIGL
Vigil Neuroscience
N/AN/AN/AN/A$1.75 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Anixa Biosciences Inc stock logo
ANIX
Anixa Biosciences
-$12.55M-$0.38N/AN/AN/A-68.17%-60.38%9/5/2025 (Estimated)
CryoPort, Inc. stock logo
CYRX
CryoPort
-$114.76M$1.336.57N/AN/A37.21%-9.79%-5.42%11/6/2025 (Estimated)
Evolus, Inc. stock logo
EOLS
Evolus
-$50.42M-$0.98N/AN/AN/A-22.31%-759.04%-24.63%11/5/2025 (Estimated)
Vigil Neuroscience, Inc. stock logo
VIGL
Vigil Neuroscience
-$84.26M-$2.05N/AN/AN/AN/A-111.70%-74.67%11/6/2025 (Estimated)

Latest ANIX, VIGL, EOLS, and CYRX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
9/5/2025Q3 2025
Anixa Biosciences Inc stock logo
ANIX
Anixa Biosciences
-$0.10N/AN/AN/AN/AN/A
8/5/2025Q2 2025
CryoPort, Inc. stock logo
CYRX
CryoPort
-$0.20-$0.29-$0.09$2.05$41.74 million$45.45 million
6/3/2025Q2 2025
Anixa Biosciences Inc stock logo
ANIX
Anixa Biosciences
-$0.10-$0.09+$0.01-$0.09N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Anixa Biosciences Inc stock logo
ANIX
Anixa Biosciences
N/AN/AN/AN/AN/A
CryoPort, Inc. stock logo
CYRX
CryoPort
N/AN/AN/AN/AN/A
Evolus, Inc. stock logo
EOLS
Evolus
N/AN/AN/AN/AN/A
Vigil Neuroscience, Inc. stock logo
VIGL
Vigil Neuroscience
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Anixa Biosciences Inc stock logo
ANIX
Anixa Biosciences
N/A
8.89
8.89
CryoPort, Inc. stock logo
CYRX
CryoPort
0.39
16.24
15.47
Evolus, Inc. stock logo
EOLS
Evolus
22.00
2.27
1.86
Vigil Neuroscience, Inc. stock logo
VIGL
Vigil Neuroscience
N/A
2.97
2.97

Institutional Ownership

CompanyInstitutional Ownership
Anixa Biosciences Inc stock logo
ANIX
Anixa Biosciences
29.13%
CryoPort, Inc. stock logo
CYRX
CryoPort
92.90%
Evolus, Inc. stock logo
EOLS
Evolus
90.69%
Vigil Neuroscience, Inc. stock logo
VIGL
Vigil Neuroscience
83.64%

Insider Ownership

CompanyInsider Ownership
Anixa Biosciences Inc stock logo
ANIX
Anixa Biosciences
25.30%
CryoPort, Inc. stock logo
CYRX
CryoPort
10.10%
Evolus, Inc. stock logo
EOLS
Evolus
6.10%
Vigil Neuroscience, Inc. stock logo
VIGL
Vigil Neuroscience
18.01%
CompanyEmployeesShares OutstandingFree FloatOptionable
Anixa Biosciences Inc stock logo
ANIX
Anixa Biosciences
532.21 million24.06 millionOptionable
CryoPort, Inc. stock logo
CYRX
CryoPort
1,18650.07 million45.01 millionOptionable
Evolus, Inc. stock logo
EOLS
Evolus
17064.68 million60.74 millionOptionable
Vigil Neuroscience, Inc. stock logo
VIGL
Vigil Neuroscience
4047.69 million39.10 millionNot Optionable

Recent News About These Companies

Vigil Neuroscience Inc Merger and Leadership Changes
Brokerages Set Vigil Neuroscience, Inc. (NASDAQ:VIGL) PT at $10.80

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Anixa Biosciences stock logo

Anixa Biosciences NASDAQ:ANIX

$2.92 -0.05 (-1.68%)
Closing price 04:00 PM Eastern
Extended Trading
$2.98 +0.06 (+2.23%)
As of 05:40 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell therapy, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the treatment of ovarian cancer. Its vaccine programs comprise the development of a vaccine against triple negative breast cancer; and a preventative vaccine against ovarian cancer. The company is also developing immuno-therapy drugs against cancer. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California.

CryoPort stock logo

CryoPort NASDAQ:CYRX

$8.66 -0.06 (-0.69%)
Closing price 04:00 PM Eastern
Extended Trading
$8.38 -0.29 (-3.29%)
As of 04:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services. It also provides CRYOGENE, an unparalleled solution that offers pre-clinical temperature-controlled biological materials management services comprising specimen storage, processing, collection, and retrieval; CRYOPD, a temperature-controlled logistics solution, which include temperature-controlled packaging and transport solutions from cryogenic temperature to controlled ambient; and IntegriCell services that comprise apheresis/leukapheresis collection, Cryoshuttle transportation, cryo-process optimization and processing services. In addition, the company offers MVE Biological Solutions' Fusion cryogenic system, a self-sustaining cryogenic freezer; MVE Biological Solutions' Vario cryogenic system, a cryogenic freezer system that supports temperatures between -20°C and -150°C; Cryoport Cryoshuttle provides clients with dedicated local transportation support; and Tec4Med. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; and incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. Cryoport, Inc. was founded in 1999 and is headquartered in Brentwood, Tennessee.

Evolus stock logo

Evolus NASDAQ:EOLS

$7.23 +0.10 (+1.40%)
Closing price 04:00 PM Eastern
Extended Trading
$7.18 -0.05 (-0.62%)
As of 05:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Evolus, Inc., a performance beauty company, focuses on delivering products in the cash-pay aesthetic market in the United States, Canada, and Europe. The company offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. It also provides dermal filler products under the Estyme and Evolysse names. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

Vigil Neuroscience stock logo

Vigil Neuroscience NASDAQ:VIGL

$8.05 0.00 (0.00%)
As of 08/5/2025

Vigil Neuroscience, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel immune cells of the brain. Its lead candidate is VGL101(Iluzanebart), a human monoclonal antibody agonist targeting human triggering receptor expressed on myeloid cells 2 and is in a Phase 2 trial in patients with adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP), a rare and fatal neurodegenerative disease. The company is also developing VG-3927, an orally-available small molecule TREM2 agonist to treat common neurodegenerative diseases associated with microglial dysfunction, with an initial focus on Alzheimer's disease in genetically defined subpopulations, which is being evaluated in a Phase 1 clinical trial. It has license agreement with Amgen Inc. to commercially develop, manufacture, use, distribute, and sell therapeutic products containing compounds that bind to TREM2. The company was incorporated in 2020 and is headquartered in Watertown, Massachusetts.